StockMarketWire.com - PHSC said its performance for the first four months of the year to the end of July 2017 was in line with the Board's expectations.

Chief Executive Stephen King said: "In the statement accompanying those results, we advised that for the first quarter of 2017-18 the group had total revenues of £1.82m and EBITDA of around £120k.

"This can now be updated to cover the four months to the end of July 2017, where the group's management accounts (unaudited) show revenues of £2.43m and EBITDA of £134k (before exceptional costs).

"This compares very favourably with an EBITDA loss of £94k on revenues of £2.3m at the same stage last year.

"The exceptional costs comprised redundancy payments in July of around £9k at our Adamson's Laboratory Services subsidiary.

"We expect to announce our interim results for the period to 30 September 2017 in early December 2017, together with detailed commentary on individual subsidiary performances."




Story provided by StockMarketWire.com